Artura Pharmaceuticals Private Limited, a active private limited company, was established on 10 February 2010 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233TN2010PTC074560. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.77 Cr.
It upholds a compliant status. Employing 87 professional, Its leadership includes Pushpakala Harirajan (Director), Vikram Harirajan (Managing Director), Damodaram Harirajan (Director). Past directors included Vikram Harirajan. It holds ₹30.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.
U24233TN2010PTC074560
074560
10 February 2010
₹5.00 Cr
₹4.77 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Artura Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pushpakala Harirajan | Director | 10 Feb 2010 | Current |
| Vikram Harirajan | Managing Director | 10 Feb 2010 | Current |
| Damodaram Harirajan | Director | 10 Feb 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Artura Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 37.16% increase. The company also saw a substantial improvement in profitability, with a 770.5% increase in profit. The company's net worth Soared by an impressive increase of 179.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Artura Pharmaceuticals had a promoter holding of 48.37% and a public holding of 51.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹302,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2025 | Indian Overseas Bank | ₹1.20 M | Open |
| 24 Sep 2021 | Indian Overseas Bank | ₹2.89 Cr | Open |
| 22 Jul 2013 | Indian Overseas Bank | ₹27.21 Cr | Open |
Explore comprehensive loan charge details -
Artura Pharmaceuticals has a workforce of 87 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Artura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artura Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Overseas Bank amounted to Rs. 0.12 Cr with Charge ID 101108856 was registered on 20 May 2025. was recorded as a recent event.
The activity Artura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Indian Overseas Bank of Rs. 27.21 Cr registered on 22 Jul 2013 with Charge ID 10439381 was modified on 31 Jul 2024. was recorded as a recent event.
Progress on Artura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on A charge with Indian Overseas Bank amounted to Rs. 2.89 Cr with Charge ID 100489805 was registered on 24 Sep 2021. was documented.
A charge with Indian Overseas Bank amounted to Rs. 27.21 Cr with Charge ID 10439381 was registered on 22 Jul 2013. was recorded as a recent event.
The CIN of Artura Pharmaceuticals Private Limited is U24233TN2010PTC074560.
Artura Pharmaceuticals Private Limited is headquartered at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.
Artura Pharmaceuticals Private Limited was incorporated on 10 February 2010.
The current directors of Artura Pharmaceuticals Private Limited are
The primary industry of Artura Pharmaceuticals Private Limited is Manufacturing.
Artura Pharmaceuticals Private Limited is unlisted.
The authorized capital of Artura Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.77 Cr.
The compliance status of Artura Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX